Scientific progress is built on failure. From penicillin to the pacemaker, many of the greatest discoveries came about by accident. And to test any hypothesis, you must first take a leap in the dark. Alphabet’s X (formally Google X) spent three years developing prototype technologies to better understand depression. The ultimate aim – to find […]
Can AI predict depression? – Verdict Medical Devices Read More »
Before the pandemic, more than 40 million people suffered with depression, and now you can likely double that number, maybe triple it. Fortunately, this problem is mostly situational, directly related to this plague-induced half-life in which we have been living for over a year now. Here are five simple (for the most part) little things
Depression hacks to lighten life | Lifestyles Read More »
TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Newscope Capital Corporation (the “Company” or “Newscope”) (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce the appointment of Dr. Maurizio Fava, MD, as a scientific
NEW YORK and TOKYO, March 16, 2021 /PRNewswire/ — Perception Neuroscience (Perception), an atai Life Sciences (atai) company focused on developing innovative therapies in neuropsychiatric disorders, and Otsuka Pharmaceutical Co., Ltd. (Otsuka), announce a collaboration and licensing agreement for the development and commercialization of Perception’s lead molecule, PCN-101 (R-ketamine) in Japan as a potential treatment
Global Major Depressive Disorder (MDD) Treatment Market Major depressive disorder (MDD), also known as clinical depression, is a mental health disorder which affects mood, behavior, as well as appetite and sleep. The exact cause of MDD is not known; however, several factors that can potentially increase its risk include a combination of genes and stress
NEW YORK and TOKYO, March 16, 2021 /PRNewswire/ — Perception Neuroscience (Perception), an atai Life Sciences (atai) company focused on developing innovative therapies in neuropsychiatric disorders, and Otsuka Pharmaceutical Co., Ltd. (Otsuka), announce a collaboration and licensing agreement for the development and commercialization of Perception’s lead molecule, PCN-101 (R-ketamine) in Japan as a potential treatment
Our bodies produce different scents when we feel happy or afraid. These so-called chemosignals – which are in fact odourless – are believed to trigger happiness or fear in others. It is one of the ways smell impacts people’s social interactions. ‘It’s like an emotional contagion. If I feel fear, my body odour will be
Courtesty: Taylor Helmes Taylor Helmes was first diagnosed as having severe depression a decade ago as a community college student. Through hard work and therapy, she poised to graduate from California State University, Dominguez Hills in May. Courtesty: Taylor Helmes Taylor Helmes was first diagnosed as having severe depression a decade ago as a community
What I wish I told my high school self about depression Read More »
Newswise — Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health. In a study of college students conducted before and during the pandemic, findings
Decreases in Exercise Closely Linked with Higher Rates of Depression during the Pandemic Read More »
Multiple brain networks contributed to the pathophysiology of major depressive disorder (MDD) including disruption of the information processing system. These findings, from an analysis of functional magnetic resonance imaging (fMRI) data, were published in the Journal of Affective Disorders. Patients (n=753) with MDD and healthy controls (n=451) were recruited from 14 hospitals in China. Participants